FIELD: organic chemistry.
SUBSTANCE: invention relates to 2-(1,1-dimethyl-1H-benzo[e]indolin-2-yl)-5,6,7-trichloro-1,3-tropolone of formula 1, which has cytotoxic activity against the culture of skin cancer cells A431 and lung cancer H1299 and can find application in the production of antitumor drugs.
(1)
EFFECT: obtaining 2-(1,1-Dimethyl-1H-benzo[e]indolin-2-yl)-5,6,7-trichloro-1,3-tropolone, which has cytotoxic activity against A431 skin cancer and H1299 lung cancer cell cultures.
10 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT HAVING CYTOTOXIC ACTIVITY ON NON-SMALL-CELL LUNG CANCER CELL CULTURE A 549 | 2020 |
|
RU2741311C1 |
| 5,7-DI(TERT-BUTYL)-2-(4,7-DICHLORO-8-METHYL-5-NITROQUINOLIN-2-YL)-4-NITRO-1,3-TROPOLONE, HAVING CYTOTOXIC ACTIVITY | 2019 |
|
RU2702648C1 |
| ANTITUMOUR AGENT FOR TREATING PROSTATE CANCER IN THE FORM OF SACHET | 2018 |
|
RU2695326C1 |
| TETRAETHYL-2-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLAMINO)-ETHYLENE-1,1-BISPHOSPHONATE POSSESSING ANTICANCER ACTIVITY | 2013 |
|
RU2506085C1 |
| NEW DRUGS WITH CYTOTOXIC ACTIVITY BASED ON AZOLOAZINE DERIVATIVES FOR BREAST CANCER CHEMOTHERAPY | 2022 |
|
RU2814965C2 |
| QUINAZOLINE DERIVATIVES INDUCING FERROPTOSIS IN METASTATIC MELANOMA CELLS AND COLON CANCER | 2019 |
|
RU2722308C1 |
| (17S)-N-BENZYL-5-((3Β-ACETOXY-28-NOR-URS-12-ENE)-17-YL)-1,3,4-OXADIAZOL-2-AMINE, HAVING SELECTIVE CELL CYTOTOXICITY BREAST CANCER MCF-7 | 2019 |
|
RU2708400C1 |
| MIXED-LIGAND COMPLEXES OF COPPER (II) WITH 1H-TETRAZOLE-5-ACETIC ACID AND OLIGOPYRIDINE DERIVATIVES, EXHIBITING CYTOTOXIC ACTIVITY | 2023 |
|
RU2818953C1 |
| USNIC ACID DERIVATIVES AS ANTI-TUMOUR AGENTS | 2013 |
|
RU2536873C1 |
| E-2-ARYL-2-TRIFLUOROMETHYL-1-NITRO-CYCLOPROPANES AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2699654C1 |
